Previous Article | Next Article 
Infection and Immunity, November 1998, p. 5477-5484, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
SCID/NCr Mice Naturally Infected with
Helicobacter hepaticus Develop Progressive Hepatitis,
Proliferative Typhlitis, and Colitis
Xiantang
Li,
James G.
Fox,*
Mark T.
Whary,
Lili
Yan,
Ben
Shames, and
Zhibao
Zhao
Division of Comparative Medicine,
Massachusetts Institute of Technology, Cambridge, Massachusetts 02139
Received 6 January 1998/Returned for modification 17 April
1998/Accepted 31 July 1998
 |
ABSTRACT |
Hepatitis, proliferative typhlitis, and colitis were characterized
in young adult and older SCID/NCr mice naturally infected with
Helicobacter hepaticus. Liver lesions consisted of Kupffer, Ito, and oval cell hyperplasia along with multifocal to coalescing coagulative hepatocyte necrosis. Numerous Warthin-Starry-positive bacteria were observed in the parenchyma, and there were minimal to
mild accumulations of monocytic cells and neutrophils. Proliferative typhlitis was characterized by moderate to marked mucosal epithelial cell hyperplasia with mild monocytic and neutrophilic infiltration. Minimal to mild colitis with mucosal epithelial cell hyperplasia of the
colon was most marked in older mice. Comparable gastrointestinal lesions were not observed in uninfected control SCID/NCr mice. H. hepaticus was cultured from fetal viscera of 2 of 11 pups sampled late in gestation from infected SCID/NCr females, suggesting
transplacental infection of H. hepaticus. As expected, most
of the naturally infected SCID/NCr mice had no serum immunoglobulin G
response against H. hepaticus. These findings contrast with
those in infected immunocompetent A/JCr mice, which develop a
significant immune response to H. hepaticus associated with
prominent multifocal mononuclear cell infiltrates in the liver, with
only rare bacteria observable at the periphery of inflammatory foci or
in the biliary canaliculi. The results demonstrate that chronic
inflammatory and proliferative lesions simultaneously affecting the
liver, cecum, and colon are associated with natural infection of
SCID/NCr mice with H. hepaticus and that lesions are
progressive with age. Concurrent infection with H. hepaticus may confound studies that have been attributed to
similar lesions due to other experimental manipulations of SCID/NCr
mice.
 |
INTRODUCTION |
Since the discovery of
Helicobacter pylori as the infectious cause of chronic,
active gastritis in humans (19, 24), additional Helicobacter species have been isolated from humans and
animals. Considerable research has focused on helicobacter-associated
diseases such as gastritis, peptic ulcers, and gastric cancers in
humans and animals (11, 12, 21, 22, 32, 44), cholecystitis in humans (13), bacteremia in immunodeficient humans
(33), and hepatitis, hepatocellular carcinoma, and
inflammatory bowel disease in mice (4, 15, 17, 29, 38-41).
Mouse models of helicobacter infection are proving to be valuable for
investigating the complex etiopathogenesis of several human idiopathic
chronic inflammatory diseases that are hypothesized to be the result of an exaggerated host response to either the normal enteric flora or
unidentified pathogens. Mouse models have allowed comparison of the
host response to persistent helicobacter infection against different
inbred genetic backgrounds as well as between various strains of mice
that differ in immunocompetence.
Helicobacter hepaticus is associated with a chronic, active
hepatitis in susceptible mouse strains including A/JCr, BALB/CAnNCr, SJL/NCr, B6C3F1, SCID/NCr, and C3H/HeNCr mice (14, 16, 17, 41). The A/JCr mouse, an immunocompetent strain, and SCID/NCr, an
immunodeficient strain, appear to be among the most disease-susceptible mouse strains identified to date, and in addition to hepatitis, H. hepaticus-infected mice develop some features of
inflammatory bowel disease. H. hepaticus infection in A/JCr
mice has been well characterized on a longitudinal basis through 18 months of age (15, 41). In this strain of mouse, H. hepaticus persists in the large bowel and liver and is associated
with a chronic proliferative hepatitis and liver cancer and, in some
mice, chronic typhlitis (15, 41). Severe transmural
typhlitis and transmural enterocolitis have also been found in
experimentally infected male A/JCr mice (43) and female
germ-free outbred mice (17), respectively. Infected A/JCr
mice develop sustained serum immunoglobulin G (IgG) antibody responses
to H. hepaticus and elevations in enzyme levels in serum
indicative of hepatocellular injury. H. hepaticus-associated hepatitis and progression to hepatocellular carcinoma is most prevalent
after 1 year postinfection. A clinical syndrome of inflammatory bowel
disease and rectal prolapse, with and without concomitant hepatitis,
has been described in several strains of genetically manipulated
immunocompromised mice, as well as young immunodeficient SCID/NCr and
nude mice infected with H. hepaticus (10, 29, 39)
and with H. bilis (31).
The importance of the immune response in either limiting colonization
or contributing to the intensity of the inflammatory response to
helicobacter infections has been widely debated. In A/JCr mice, the
development of helicobacter-associated lesions, particularly hepatitis
and typhlitis, has been associated with the concomitant development of
a significant serum IgG and Th1 cell-mediated immune response to
H. hepaticus antigens that intensifies over the course of
infection (15, 38, 41, 43). Antibody responses to H. hepaticus infection tend to be low in strains of mice that are
persistently colonized in the gut but do not develop hepatitis, whereas
significant serum antibody to H. hepaticus antigens is
demonstrable in strains of mice that do develop hepatitis (42). Ward et al. reported that mice infected with H. hepaticus develop antibodies to hsp70 expressed both by H. hepaticus and diseased hepatocytes and suggested that such
cross-reactive host responses may contribute to lesion development
(40). SCID C.B-17 mice reconstituted with memory
CD45RBhigh CD4+ T cells developed severe
inflammatory bowel disease when concurrently infected experimentally
with H. hepaticus, in contrast to a lower incidence in
nonreconstituted but infected immunodeficient controls (4).
However, when SCID C.B-17 and congenic immunocompetent mice were
experimentally infected with H. felis to model H. pylori gastritis, similar grades of gastritis and colonization
developed in mice incapable and capable, respectively, of mounting an
immune response to H. felis, suggesting that the antibody
response to helicobacters is not necessary to induce disease
(2).
In the present study, we assessed the extent of hepatitis,
proliferative typhlitis, and colitis that developed in SCID/NCr mice
naturally infected with H. hepaticus up to the age of 10 months. The objective was to evaluate if the severity of H. hepaticus-associated lesions is progressive with age in an
immunodeficient host genotype, as has been established in older
H. hepaticus-infected A/JCr mice (15, 41, 43). In
addition, because H. hepaticus-infected SCID/NCr mice
have many more bacteria observable within the liver than do the
infected but immunocompetent A/JCr mice, we determined if
transplacental infection of fetuses with H. hepaticus
occurred in these mice.
 |
MATERIALS AND METHODS |
Animals.
In the first part of this retrospective
study, SCID/NCr mice naturally infected with H. hepaticus
were kindly supplied by the National Cancer Institute (Frederick, Md.)
(14, 41). These included 9 young adult males (4 to 6 months
old), 14 older males (9 to 10 months old), and 8 pregnant females (6 to
8 months old). After the colony had been rederived to eliminate
H. hepaticus, 6 older (9 to 10 months old) male SCID/NCr
mice that were confirmed to be H. hepaticus free were
evaluated as negative controls. In addition, 11 fetuses from 8 pregnant
SCID/NCr mice and 14 fetuses from 4 pregnant A/JCr mice naturally
infected with H. hepaticus were sampled for evidence of
transplacental transmission of the infection. Upon arrival, the mice
were either necropsied immediately or briefly housed under isolated,
quarantine conditions in a facility accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care.
Necropsy sampling.
At necropsy, samples of the cecum, colon,
and liver were collected aseptically for culture and PCR to identify
H. hepaticus in tissues. In pregnant female mice, fetuses
were aseptically removed from the uterus and the fetal viscera were
ground and then cultured for H. hepaticus. Liver samples
were processed in Karnovsky's fixative for transmission electron
microscopy. The remaining tissues from each mouse were fixed in neutral
buffered 10% formalin for histopathological and immunofluorescence
evaluation.
Histopathology.
After 24 h of fixation in formalin,
tissue samples were embedded in paraffin, sectioned at 5 µm, and
stained with hematoxylin-eosin and by the Warthin-Starry method.
Samples were taken from each liver lobe longitudinally from the apical
or free margin to the hilus. Separate sections of liver, cecum, and
colon were mounted on Probe-On Plus slides (Fisher, Pittsburgh, Pa.) to
demonstrate the bacterium in tissues by immunofluorescence.
Liver lesions were graded for hepatocyte necrosis, inflammatory cell
infiltrates in the parenchyma, periportal and perivenous areas, oval
cell and bile duct hyperplasia, Kupffer and Ito cell hyperplasia, and
hepatocyte pleomorphism. Each of these parameters was graded
semiquantitatively as 0 (normal), 1 (minimal; <5% involvement), 2 (mild; 5 to 25% involvement), 3 (moderate; 25 to 50% involvement) or
4 (severe; >50% involvement) in the liver. The score from each parameter was averaged for each mouse and then compared for each group.
The cecum and colon were examined for the extent of inflammatory cell
infiltrates in the wall, especially the mucosa and submucosa, and for
epithelial cell hyperplasia by using the same grading system. Lesion
scores were compared for significant differences by the Mann-Whitney
test for nonparametric statistics.
Immunofluorescence.
Liver, cecum, and colon samples were
processed for immunofluorescence by using polyclonal rabbit
anti-H. hepaticus sera (15). Briefly, tissue
sections were deparaffinized in xylene and rehydrated through ethanol
to water. The sections were preincubated with normal rabbit serum
(Sigma, St. Louis, Mo.) for 5 min to block nonspecific binding and then
incubated with anti-H. hepaticus serum at 1:100 dilution.
Fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (Sigma) at a
1:50 dilution was then applied. The slides were rinsed with
phosphate-buffered saline (PBS) between staining steps, and incubations
were done in a humid chamber at room temperature for 1 h. After a
final wash with PBS, the slides were coverslipped with buffered
glycerol and examined under a Zeiss fluorescent microscope. Control
staining was performed in the same manner except that normal rabbit
serum was substituted for the polyclonal antibody.
Transmission electron microscopy.
Liver samples were fixed
in Karnovsky's fixative, postfixed with 1% osmium tetroxide,
dehydrated through graded acetone, and embedded in Epon-Araldite 6005 mixture (23). The plastic blocks were semi-thin sectioned at
1 µm and stained with methylene blue/azure II. The areas of interest
were identified under a light microscope, cut from the plastic block,
and mounted to a plastic bean capsule. A 50- to 70-nm-thick section was
then cut, stained with uranyl acetate-lead citrate, and visualized with
a transmission electron microscope.
Bacterial isolation.
Samples of the liver, cecum, and colon
were collected aseptically from each mouse and from the viscera of 20- to 21-day-old SCID/NCr (n = 11) and A/JCr
(n = 14) pups aseptically harvested in utero. The
tissues were homogenized in 1 ml of PBS, filtered through a
0.45-µm-pore-size nylon filter (Millipore, Bedford, Mass.), and
cultured for H. hepaticus on blood agar supplemented with
1% trimethoprim, vancomycin, and polymyxin (Remel Labs, Lenexa, Kans.). The plates were incubated at 37°C under microaerobic
conditions in vented jars (90% N2, 5% H2, 5%
CO2). Cultured organisms were evaluated biochemically by
measuring urease production and morphologically by Gram stain and
phase-contrast microscopy.
PCR.
PCR evaluation of liver, cecum, and colon samples was
performed to supplement previously described (30) culture
techniques to confirm infection with H. hepaticus. Briefly,
bacterial DNA was isolated from tissue samples by the alkali lysis
method. The DNA pellet was then redissolved in sterile distilled water.
Two oligonucleotides, 5' GCA TTT GAA ACT GTT ACT CTG 3' and 5' CTG TTT
TCA AGC TCC CC 3', were used as primers for amplification. These
primers recognize an H. hepaticus-specific region of the 16S
rDNA and produce an amplified product of 417 bp. A total of 35 cycles
were performed at 94, 61, and 72°C for 1, 2 1/4, and 2 1/2 min,
respectively, followed by an elongation step for 7 min at 72°C. The
PCR products were separated by electrophoresis on a 6% Visigel
separation matrix gel (Stratagene, La Jolla, Calif.), stained with
ethidium bromide, and visualized with UV illumination.
ELISA for serum IgG.
Serum was collected at necropsy and
screened for serum IgG specific for H. hepaticus antigens by
using a standard enzyme-linked immunosorbent assay (ELISA) method
described previously (43). Positive and negative controls
for detection of serum IgG specific for H. hepaticus
antigens were A/JCr male mice that had been experimentally infected
with H. hepaticus for 1 year or were known to be H. hepaticus free, respectively.
 |
RESULTS |
Pathologic findings.
Grossly, two 4-month-old and one
6 month-old young adult males had single to multiple yellow to gray
necrotic foci 0.5 to 2 mm in diameter in one or more liver lobes. Older
males and pregnant females had a variably prominent reticular pattern
in one or more liver lobes. The cecal wall and/or mucosa was mildly to
moderately thickened, and the mucosa appeared to be rough or granular
in selected older males and two pregnant females. The severity of the
histologic changes in the liver, cecum, and colon is shown in Fig.
1. The major findings in the liver are
illustrated in Fig. 2 to 7, and those in
the cecum and colon are illustrated in Fig. 8 to 10.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Severity of liver, cecum, and colon lesions in H. hepaticus-infected young adult males, older males, and pregnant
female SCID/NCr mice. Individual histologic scores and medians are
shown. Older males had more severe hepatitis than pregnant females
(P < 0.0032) but there was only a trend for older
males to have more severe lesions than younger males. The extents of
typhlitis, cecal epithelial hyperplasia, and colitis were similar among
groups. Older males had greater colonic epithelial hyperplasia than did
younger males or pregnant females (P < 0.05).
|
|

View larger version (201K):
[in this window]
[in a new window]
|
FIG. 2.
Liver section from an adult male SCID/NCr mouse.
Multifocal coagulative necrosis (N) of hepatocytes and inflammatory
cell infiltration at the periphery and in the periportal and perivenous
areas (V) are visible. Bar, 170 µm.
FIG. 3.
Liver section from a pregnant female SCID/NCr mouse. Mild
infiltration of mononuclear cells and neutrophils in the periportal and
perivenous areas (V) and variation in hepatocellular size and shape are
visible. Bar, 70 µm.
FIG. 4.
Liver section from an older male SCID/NCr mouse. Oval cell
hyperplasia with formation of bile ductules (arrows), hepatocytomegaly
and karyomegaly, and inflammatory cell infiltration are visible. Bar,
48 µm.
FIG. 5.
Liver section from an older male SCID/NCr mouse.
Hepatocytomegaly and karyomegaly (M) surrounded by inflammatory cells
and hyperplasia or hypertrophy of oval and Kupffer cells (arrows) are
visible. Bar, 46 µm.
FIG. 6.
Liver section from an older male SCID/NCr mouse.
Warthin-Starry stain reveals many spiral H. hepaticus cells
with the hepatic parenchyma or between the hepatocytes (arrows). Bar,
10 µm.
FIG. 7.
Liver section from an older male SCID/NCr mouse. Electron
microscopy reveals several spiral-shaped H. hepaticus
organisms in a bile canaliculus (arrows), some with a flagellum (open
arrows). Bar, 0.7 µm.
|
|
The predominant lesions in the livers of infected SCID/NCr mice were
multifocal to coalescing coagulative necrosis of the
hepatocyte
parenchyma with minimal to mild infiltration of macrophages
and
neutrophils at the periphery (Fig.
2). The size of the necrotic
foci
varied from a few to numerous hepatocytes. Inflammatory cell
infiltration was minimal to mild in the remaining parenchyma and
periportal areas. In the livers of pregnant female SCID/NCr mice,
mild
infiltration of mononuclear cells and neutrophils was observed
in the
periportal and perivenous areas, with marked variation
in
hepatocellular size and shape (Fig.
3). In older males, inflammatory
cell infiltration was also mild, but Kupffer cell, Ito cell, and
oval
cell hyperplasia or hypertrophy and hepatocyte pleomorphism
were
prominent in the affected livers (Fig.
4). A small number
of
macrophages and neutrophils accumulated multifocally in the
parenchyma
and periportal and perivenous areas. Some of the macrophages
and
Kupffer cells contained intracytoplasmic yellow to brown pigment.
Hyperplastic oval cells radiated from the inflamed foci to adjacent
hepatic parenchyma and sometimes bridged to adjacent portal areas,
with
occasional formation of bile ductules. Hepatocyte necrosis
became less
prominent in the parenchyma, but cytomegaly and karyomegaly
of the
hepatocytes were marked, with frequent intranuclear pseudoinclusions
(Fig.
5). Collapse of hepatic plates and capsular surfaces due
to the
loss of hepatocytes was observed frequently. Hepatic changes
in the
younger males were similar but tended to be less severe
than those in
the older males; pregnant females had significantly
less severe changes
than did older males (
P < 0.0032) (Fig.
1).
Altered or
adenomatous hepatocellular foci were not observed in
the livers of any
mice. All six of the older male
H. hepaticus-free
control
SCID/NCr mice were free of comparable lesions in the liver
(except for
focal, peribiliary accumulations of histiocytic cells,
not shown),
cecum (see Fig.
8B), or colon (see Fig.
10B).
Warthin-Starry stain revealed that numerous
H. hepaticus
organisms were present in the liver parenchyma and the cecal and
colonic mucosa of all infected mice but were absent from the liver
sections of control mice. In the livers of infected mice, bacteria
appeared localized between hepatocytes (Fig.
6). The severity
of the
hepatic lesions appeared to be associated with a relative
abundance of
bacteria. By transmission electron microscopy, spiral
bacteria with
morphology consistent with
H. hepaticus were observed
within
bile canaliculi of affected livers (Fig.
7). The bile canaliculi
were
variably dilated, with swelling, blunting, and decreased
numbers of
canalicular microvilli. The hypertrophic hepatocytes
contained abundant
mitochondria and/or endoplasmic reticulum.
Cytoplasmic invagination
into nuclei was frequently seen (intranuclear
pseudoinclusions were
seen histologically). Hyperplastic or hypertrophic
Ito cells often had
markedly vacuolated cytoplasm and peripherally
displaced nuclei.
Hyperplastic or hypertrophic oval cells often
formed small ductules,
with variably patent lumina and intercellular
junctional structures.
Proliferative typhlitis was observed in all infected mice except for
one pregnant female (Fig.
1). Inflammatory cell infiltration,
consisting mainly of macrophages and neutrophils, was mild, but
mucosal
epithelial cell hyperplasia was moderate to marked in
all affected
mice, particularly in two pregnant females (Fig.
8). The mucosa was markedly thickened,
with frequent villous to
papillomatous folds extending into the lumen.
Epithelial cells
were markedly basophilic and densely piled up and had
a high mitotic
index. Goblet cells were variably decreased in number or
were
completely absent in the proliferative mucosa. In the cecum and
colon, bacteria morphologically consistent with
H. hepaticus
were
located within the crypts or glandular lumen of the mucosa (Fig.
9). Minimal to mild colitis was seen in
most mice in each group,
whereas mucosal epithelial cell hyperplasia
was observed in 11
of 14 older males and in 2 of 7 pregnant females and
was absent
in younger males (0 of 9) (Fig.
10).

View larger version (154K):
[in this window]
[in a new window]

View larger version (88K):
[in this window]
[in a new window]
|
FIG. 8.
(A) Cecum section from a pregnant female SCID/NCr mouse.
Marked epithelial cell hyperplasia in the mucosa villous folding of the
mucosa into the cecal lumen, with many mitotic figures (arrows), and
mild inflammatory cell infiltration in the mucosa are visible. Bar, 63 µm. (B) Cecum section from a control uninfected older male SCID/NCr
mouse. In comparison to the cecum from an infected mouse (A), note the
absence of mononuclear cells and mitotic figures and the normal, thin
epithelial cell layer. Magnification, ×100.
|
|

View larger version (145K):
[in this window]
[in a new window]
|
FIG. 9.
Colon section from a pregnant female SCID/NCr mouse.
Warthin-Starry stain reveals many spiral H. hepaticus-like
organisms within a crypt (arrows). Bar, 9 µm.
|
|

View larger version (157K):
[in this window]
[in a new window]

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 10.
(A) Colon section from an older infected male SCID/NCr
mouse. Note the mild inflammatory infiltrate of histiocytes and
hyperplasia of mucosal epithelial cells. Magnification, ×100. (B)
Colon section from a control older uninfected male SCID/NCr mouse. In
comparison to the colon from an infected mouse (A), note the absence of
mononuclear cells and the normal, thin epithelial cell layer.
Magnification, ×100.
|
|
Two infected SCID/NCr mice had a measurable serum IgG response to
H. hepaticus by ELISA (see "ELISA for serum IgG"). The
lesion
severity scores for one of the two mice, an older male SCID/NCr
mouse, were hepatitis [3], typhlitis [2] with epithelial cell
hyperplasia in the cecum (
2) and colitis [1] with
epithelial
cell hyperplasia in the colon [1]; scores for the second
mouse,
a pregnant female, were hepatitis [2], typhlitis [3] with
epithelial
cell hyperplasia in the cecum [4], and colitis [2] with
epithelial
cell hyperplasia in the colon [2].
Immunofluorescence.
As with the Warthin-Starry stain,
immunofluorescence with anti-H. hepaticus serum revealed
numerous organisms in the liver parenchyma. Some uninfected mice had
very weakly fluorescent, scattered positive granules in the cytoplasm
of a few hepatocytes, which may be due to cross-reactivity of the
antisera with intracytoplasmic components. However, the pattern and
intensity of the positive fluorescence in uninfected mice were clearly
of a much lower magnitude from that observed in infected mice. The
number of positive-staining helical bacteria appeared to correlate with
the severity of hepatitis in the infected SCID/NCr mice. There were no
positive-staining bacteria without evidence of hepatitis, nor were any
bacteria noted in the livers of control mice.
Bacterial culture.
Bacterial cultures of selected liver,
cecal, and colonic samples were performed for the control group of six
older male SCID/NCr mice and for the naturally infected mice. The older
male control SCID/NCr mice were free of H. hepaticus by
culture of liver and cecal tissue. Samples of viscera from 2 of the 11 SCID/NCr fetuses were culture positive for H. hepaticus,
whereas no recovery of H. hepaticus was obtained from any of
the 14 A/JCr fetuses. Colonic cultures were 100% positive for recovery
of H. hepaticus from SCID/NCr young adult males and pregnant
females, and cecal cultures were all positive for recovery of H. hepaticus from young adult males and from five of seven pregnant
females. Colonic and cecal cultures were contaminated in six of six
older males, and the culture results were not interpretable. Liver
cultures were positive for H. hepaticus in five of eight
young adult males, nine of nine older males, and six of eight pregnant
females. Bacterial cultures of the liver, cecal, and colonic samples
were positive for H. hepaticus in at least one sample per
mouse; therefore, on a cumulative basis, each mouse was H. hepaticus positive.
PCR.
The results of PCR analysis of H. hepaticus in
tissue samples correlated well with those of bacterial culture. Liver,
cecal, and colonic samples from pregnant females and older males were all positive for H. hepaticus. An amplified product of 417 bp was produced and visualized for each sample. For four older males for which the bacterial culture was contaminated, PCR analysis of
specimens were all positive for H. hepaticus. Control mice were negative for all Helicobacter spp. by PCR.
ELISA for serum IgG.
Serum samples from the SCID/NCr mice were
compared by an H. hepaticus-specific ELISA to sera obtained
from male A/JCr mice that had been experimentally infected with
H. hepaticus for 1 year (positive controls) and to negative
control sera obtained from H. hepaticus-free male A/JCr
mice. The mean ELISA values measured for SCID/NCr mice of all age
groups were lower than the mean value measured for the negative control
A/JCr mice, indicating the absence of serum IgG to H. hepaticus in the SCID/NCr mice (Fig.
11). The positive control A/JCr mice
had a high IgG response to H. hepaticus antigens. Serum from
one older male and one pregnant female SCID/NCr mice yielded ELISA
optical density values (0.94 and 0.78, respectively) that exceeded the
mean plus 3 standard deviations of the ELISA values measured for the
negative A/JCr mice (0.67), suggesting that these SCID/NCr mice were
"leaky" and had developed some serum antibody to H. hepaticus.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 11.
Mean and standard deviation (error bars) of an ELISA
measurement of serum IgG specific for H. hepaticus antigens.
Only the positive control A/JCr mice infected with H. hepaticus for 1 year had a significant antibody response. OD,
optical density.
|
|
 |
DISCUSSION |
Hepatitis, proliferative typhlitis, and colitis with progressive
mucosal hyperplasia were characterized in this study of young adult
male, pregnant female, and older male SCID/NCr mice naturally infected
with H. hepaticus. Consistent with the results of previous experiments examining the effects of age and sex on the pathogenesis of
H. hepaticus infection in A/JCr mice (15, 43),
older males had significantly more severe hepatitis than did pregnant
females and there was a trend for more severe lesions in the older
males than in the younger males. All the infected mice had similar
grades of mild to moderate typhlitis and minimal to mild colitis, but colonic mucosal hyperplasia was most severe in older males and notably
absent in younger males and most pregnant females. This study is the
first to show that colonic mucosal hyperplasia associated with
persistent H. hepaticus infection in male SCID/NCr mice
becomes more severe with age. Although control groups were not
evaluated because uninfected SCID/NCr mice were not available at the
time, subsequent analysis of older, uninfected SCID/NCr male mice and previous studies of control, uninfected SCID C.B-17 mice (4, 31) indicated that these findings are consistent with a
hypothesis that a chronic inflammatory response to bacterial infection
may be a cofactor for some forms of idiopathic hepatic disease
(13) and inflammatory bowel disease (4, 28, 36).
In addition, recovery of H. hepaticus from a limited number
of near-term fetuses carried by infected SCID/NCr dams raises new
concerns that transplacental infection of H. hepaticus may
occur in naturally infected immunodeficient mice.
As expected, most SCID/NCr mice infected with H. hepaticus
did not have detectable serum IgG against H. hepaticus
antigens. The two SCID/NCr mice with a measurable antibody response
were apparently leaky, a term used to describe the emergence of
functional B cells in older SCID mice (1). These two mice
had mild to severe lesions that varied by tissue (see Results). Because
only two mice were leaky and their lesion scores were not significantly different from those of other mice within the same cohort, conclusive statements about the significance of their antibody response to H. hepaticus cannot be made. By light and electron
microscopy, numerous bacteria with a morphology consistent with
H. hepaticus were observed in the crypts of the cecum and
colon of all infected mice and between hepatocytes or within bile
canaliculi of the majority of the infected SCID/NCr mice. Persistence
of infection was also supported by both bacterial culture and PCR
analysis of liver, cecal, and colonic samples that were positive for
H. hepaticus in at least one tissue per mouse. Recovery of
H. hepaticus by culture from the livers of these naturally
infected SCID/NCr mice was higher than in previous attempts to culture
H. hepaticus from immunocompetent, naturally infected A/JCr
mice (14, 15). Additionally, hepatic inflammation was less
severe in the SCID/NCr mice than in the infected A/JCr mice, which have
been shown to respond to H. hepaticus with a proinflammatory
Th1-cell-mediated immune response (43). Taken together, the
more moderate inflammatory response and larger number of organisms in
SCID/NCr mice than in immunocompetent A/JCr mice support the role of an
adaptive immune response in limiting colonization of the liver with
H. hepaticus. This suggests that the immune response
inhibits colonization and/or clearance of the bacteria from the liver
by potentially preventing bacterial adherence to the mucosa by IgA, by
antibody-mediated killing of bacteria by Fc-receptor positive
phagocytic cells, and by complement-mediated bacterial cell lysis.
SCID/NCr mice also are deficient in important T-cell-mediated responses
that have been shown to be proinflammatory in H. hepaticus-infected AJ/Cr mice (43).
There also is evidence the host immune response has limited ability to
restrict helicobacter replication and spread, particularly during
mucosal surface infection. Not only can some intestinal helicobacters
colonize the liver, but also vertical transmission of a helicobacter
was first proposed when "H. rappini" was suspected to
have crossed the placenta and caused hepatic necrosis in fetuses during
natural infection in presumably immunocompetent sheep (3). The same isolate reproduced liver necrosis in the fetuses when given as
an experimental challenge to pregnant guinea pigs (3). The
apparent transplacental H. hepaticus infection in the
SCID/NCr mice in our study suggests that immunodeficiency is a
contributing factor; more studies are needed before definitive
conclusions can be made. A role for the adaptive immune response in
limiting helicobacter colonization or influencing the extent of
inflammation was not supported by studies of H. felis-induced gastritis in SCID C.B-17 mice (2). The
number of H. felis organisms was not statistically different
between immunodeficient and congenic immunocompetent mice, and the two
groups of mice had similar grades of gastritis. There are important
differences between the H. felis and H. hepaticus
mouse models that may explain the disparity between the immune status
and the ability or inability to limit bacterial colonization. The
H. felis mouse model involves a gastric mucosal infection
produced by an acute experimental challenge with a large number of
organisms that are not naturally acquired mouse pathogens. In contrast,
natural infection of the mouse with H. hepaticus results in
colonization of the lower bowel in virtually all mouse strains
examined, but colonization of the liver occurs only in select inbred
strains, indicating that genetic factors such as those that regulate
the immune response are critical to host defense. Lesions observed to
develop in the infected SCID/NCr mice in this study may have been
promoted by other host and bacterial virulence factors suspected to be
involved in the pathogenesis of helicobacter infection and disease. In
brief, these include chemotactic factors released from monocytes and
neutrophils, as well as bacterial release of cytotoxin, urease, and
lipopolysaccharide (5-8, 20, 25-27, 34, 35, 37, 43).
Our results with younger SCID/NCr mice are similar to other
descriptions of H. hepaticus-associated hepatitis, typhlitis
with or without associated colitis, and proctitis with rectal prolapse in young SCID and other immunodeficient mice (10, 29, 38, 39). Interestingly, our data demonstrates that colonic mucosal proliferation was more severe in older than in younger male H. hepaticus-infected SCID/NCr mice. Mild to severe typhlitis has been observed occasionally in infected A/JCr mice (15, 34, 39,
43). In contrast, proliferative typhlitis was marked and consistent in the SCID/NCr mice. The lesions of H. hepaticus-associated hepatitis and proliferative typhlitis found
in a small number of male SCID/NCr mice from the age of 7 weeks through
5 months (29) were very similar to the lesions noted in the
4- to 6-month-old male mice in our study. We recently described
inflammatory large bowel disease with rectal prolapse in several
strains of immunodeficient mice infected with H. hepaticus,
including six female SCID/NCr mice that were 32 to 42 weeks old
(39). All of the mice had variable degrees of proliferative
typhlitis, colitis, and proctitis with rectal prolapse, but concomitant
hepatitis was rarely observed. This low incidence of hepatitis may be
related to the fact that only 9 of 64 mice examined were male and these
male mice were on a C57BL/6 background, which is resistant to the
development of helicobacter-associated hepatitis (40). The
H. hepaticus-infected SCID/NCr mice examined in this study
showed consistent development of hepatitis and proliferative typhlitis
and variable colitis, without concomitant proctitis and rectal
prolapse. The difference in the extent and distribution of lesions
between mice of similar genetic backgrounds is currently unexplained,
but environmental factors (18) and the interaction of
H. hepaticus with other resident enteric bacteria
(9) have received the most emphasis. Thus, the mechanisms
that govern the spectrum of disease manifestation in H. hepaticus-infected mice cannot be attributed solely to the host
immune response and appear to be multifactorial.
 |
ACKNOWLEDGMENTS |
This research was supported in part by NIH grants RO1 CA 67529, RO1 DK 52413, and RR 07036.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Comparative Medicine, Massachusetts Institute of Technology, 77 Massachusetts Ave., Bldg. 16-825C, Cambridge, MA 02139. Phone: (617)
253-1757. Fax: (617) 258-5708. E-mail: jgfox{at}mit.edu.
Present address: Animal Resources Center, University of Chicago,
Chicago, IL 60637.
Editor:
J. R. McGhee
 |
REFERENCES |
| 1.
|
Ansell, J. D., and G. J. Bancroft.
1989.
The biology of the SCID mutation.
Immunol. Today
10:322-325[Medline].
|
| 2.
|
Blanchard, T. G.,
S. J. Czinn,
J. G. Nedrud, and R. W. Redline.
1995.
Helicobacter-associated gastritis in SCID mice.
Infect. Immun.
63:1113-1115[Abstract].
|
| 3.
|
Bryner, J. H.,
A. E. Ritchie,
L. Pollet,
C. A. Kirkbride, and J. E. Collins.
1987.
Experimental infection and abortion of pregnant guinea pigs with a unique spirillum-like bacterium isolated from aborted ovine fetuses.
Am. J. Vet. Res.
48:91-97[Medline].
|
| 4.
|
Cahill, R. J.,
C. J. Foltz,
J. G. Fox,
C. A. Dangler,
F. Powrie, and D. B. Schauer.
1997.
Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus.
Infect. Immun.
65:3126-3131[Abstract].
|
| 5.
|
Censini, S.,
C. Lange,
Z. Y. Xiang,
J. E. Crabtree,
P. Ghiara,
M. Borodovsky,
R. Rappuoli, and A. Covacci.
1996.
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors.
Proc. Natl. Acad. Sci. USA
93:14648-14653[Abstract/Free Full Text].
|
| 6.
|
Cover, T. L.,
P. Cao,
C. D. Lind,
K. T. Tham, and M. J. Blaser.
1993.
Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo.
Infect. Immun.
61:5008-5012[Abstract/Free Full Text].
|
| 7.
|
Craig, P. M.,
M. C. Territo,
W. E. Karnes, and J. H. Walsh.
1992.
Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils.
Gut
33:1020-1023[Abstract/Free Full Text].
|
| 8.
|
Davies, G. R.,
N. Banatvala,
C. E. Collins,
M. T. Sheaff,
Y. Abdi,
L. Clements, and D. S. Rampton.
1994.
Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa.
Scand. J. Gastroenterol.
29:419-424[Medline].
|
| 9.
|
Dianda, L.,
A. M. Hanby,
N. A. Wright,
A. Sebesteny,
A. C. Hayday, and M. J. Owen.
1997.
T cell receptor- -deficient mice fail to develop colitis in the absence of a microbial environment.
Am. J. Pathol.
150:91-97[Abstract].
|
| 10.
|
Foltz, C. J.,
J. G. Fox,
R. Cahill,
J. C. Murphy,
L. Yan,
B. Shames, and D. Schauer.
1998.
Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus.
Helicobacter
3:69-78[Medline].
|
| 11.
|
Forman, D.
1996.
Helicobacter pylori and gastric cancer.
Scand. J. Gastroenterol.
214:31-33.
|
| 12.
|
Fox, J. G.,
C. A. Dangler,
M. T. Whary,
W. Edelman,
R. Kucherlapati, and T. C. Wang.
1997.
Mice carrying a truncated Apc gene have diminished epithelial proliferation, gastric inflammation, and humoral immunity in response to Helicobacter felis infection.
Cancer Res.
57:3972-3978[Abstract/Free Full Text].
|
| 13.
|
Fox, J. G.,
F. E. Dewhirst,
Z. Shen,
N. S. Taylor,
B. J. Paster,
R. L. Ericson,
C. N. Lau,
P. Correa,
J. C. Araya, and I. Roa.
1998.
Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis.
Gastroenterology
114:755-763[Medline].
|
| 14.
|
Fox, J. G.,
F. E. Dewhirst,
J. G. Tully,
B. J. Paster,
L. Yan,
N. S. Taylor,
M. J. Collins, Jr.,
P. L. Gorelick, and J. M. Ward.
1994.
Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.
J. Clin. Microbiol.
32:1238-1245[Abstract/Free Full Text].
|
| 15.
|
Fox, J. G.,
X. Li,
L. Yan,
R. J. Cahill,
R. Hurley,
R. Lewis, and J. C. Murphy.
1996.
Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of Helicobacter-induced carcinogenesis.
Infect. Immun.
64:1548-1558[Abstract].
|
| 16.
|
Fox, J. G.,
J. MacGregor,
Z. Shen,
X. Li,
R. Lewis, and C. A. Dangler.
1998.
Comparison of methods of identifying Helicobacter hepaticus in B6C3F1 mice used in a carcinogenesis bioassay.
J. Clin. Microbiol.
36:1382-1387[Abstract/Free Full Text].
|
| 17.
|
Fox, J. G.,
L. Yan,
B. Shames,
J. Campbell,
J. C. Murphy, and X. Li.
1996.
Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus.
Infect. Immun.
64:3673-3681[Abstract].
|
| 18.
|
Gaskins, H. R.,
G. L. Vondrak-Juergens,
B. A. McCracken, and J. H. Woolsey.
1997.
Specific-pathogen-free conditions enhance inflammatory bowel disease in T-cell receptor knockout, but not C3H/HeJBir mice.
Lab. Anim. Sci.
47:650-655[Medline].
|
| 19.
|
Goodwin, C. S., and B. W. Worsley.
1993.
The helicobacter genus: the history of H. pylori and taxonomy of current species, p. 1-13.
In
C. S. Goodwin, and B. W. Worsley (ed.), Helicobacter pylori: biology and clinical practice. CRC Press, Boca Raton, Fla.
|
| 20.
|
Hewett, J. A., and R. A. Roth.
1993.
Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides.
Pharmacol. Rev.
45:381-411.
|
| 21.
| Lee, A. 1994. The use of a mouse model in the study
of Helicobacter sp.-associated gastric cancer. Eur. J. Gastroenterol. Hepatol. 6(Suppl. 1):S67-S71.
|
| 22.
|
Lee, A.,
J. Fox, and S. Hazell.
1993.
Pathogenicity of Helicobacter pylori: a perspective.
Infect. Immun.
61:1601-1610[Free Full Text].
|
| 23.
|
Li, X., and W. L. Castleman.
1990.
Ultrastructural morphogenesis of 4-ipomeanol-induced bronchiolitis and interstitial pneumonia in calves.
Vet. Pathol.
27:141-149[Abstract].
|
| 24.
|
Marshall, B. J.,
H. Royce,
D. I. Annear,
C. S. Goodwin,
J. W. Pearman,
J. R. Warren, and J. A. Armstrong.
1984.
Original isolation of Campylobacter pyloridis from human gastric mucosa.
Microbios Lett.
25:83-86.
|
| 25.
|
McCathey, S.,
M. T. Whary,
N. S. Taylor,
C. A. Dangler, and J. G. Fox.
1997.
In vivo administration of Helicobacter hepaticus cytotoxin is associated with hepatic inflammation and necrosis.
Lab. Anim. Sci.
47:440. (Abstract.)
|
| 26.
|
Moran, A. P.
1996.
The role of lipopolysaccharide in Helicobacter pylori pathogenesis.
Aliment. Pharmacol. Ther.
10:39-50.
|
| 27.
|
Nielsen, H.,
S. Birkholz,
L. P. Andersen, and A. P. Moran.
1994.
Neutrophil activation by Helicobacter pylori lipopolysaccharides.
J. Infect. Dis.
170:135-139[Medline].
|
| 28.
|
Powrie, F., and M. W. Leach.
1995.
Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation.
Ther. Immunol.
2:115-123[Medline].
|
| 29.
|
Russell, R. J.,
D. C. Haines,
M. R. Anver,
J. K. Battles,
P. L. Gorelick,
L. L. Blumenauer,
M. A. Gonda, and J. M. Ward.
1995.
Use of antibiotics to prevent hepatitis and typhlitis in male scid mice spontaneously infected with Helicobacter hepaticus.
Lab. Anim. Sci.
45:373-378[Medline].
|
| 30.
|
Shames, B.,
J. G. Fox,
F. Dewhurst,
L. L. Yan,
Z. L. Shen, and N. S. Taylor.
1995.
Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay.
J. Clin. Microbiol.
33:2968-2972[Abstract].
|
| 31.
|
Shomer, N. H.,
C. A. Dangler,
M. D. Schrenzel, and J. G. Fox.
1997.
Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora.
Infect. Immun.
65:4858-4864[Abstract].
|
| 32.
| Sipponen, P., and H. Hyvarinen. 1993. Role of
Helicobacter pylori in the pathogenesis of gastritis, peptic
ulcer and gastric cancer. Scand. J. Gastroenterol.
196(Suppl.):3-6.
|
| 33.
|
Trivettmoore, N. L.,
W. D. Rawlinson,
M. Yuen, and G. L. Gilbert.
1997.
Helicobacter westmeadii sp. nov, a new species isolated from blood cultures of two AIDS patients.
J. Clin. Microbiol.
35:1144-1150[Abstract].
|
| 34.
|
Tummuru, M. K. R.,
S. A. Sharma, and M. J. Blaser.
1995.
Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells.
Mol. Microbiol.
18:867-876[Medline].
|
| 35.
|
Valkonen, K. H.,
T. Wadstrom, and A. P. Moran.
1994.
Interaction of lipopolysaccharides of Helicobacter pylori with basement membrane protein laminin.
Infect. Immun.
62:3640-3648[Abstract/Free Full Text].
|
| 36.
|
Viney, J. L.
1998.
Altering cytokine soups: a recipe for inflammatory bowel disease?
Gut
42:607-608[Free Full Text].
|
| 37.
|
Wadstrom, T.,
J. Rydberg,
B. Rozalska, and J. Lelwala-Guruge.
1994.
Intravenous Helicobacter pylori induces low levels of TNF- and IL-1 in a murine model.
APMIS
102:49-52[Medline].
|
| 38.
|
Ward, J. M.,
M. R. Anver,
D. C. Haines, and R. E. Benveniste.
1994.
Chronic active hepatitis in mice caused by Helicobacter hepaticus.
Am. J. Pathol.
145:959-968[Abstract].
|
| 39.
|
Ward, J. M.,
M. R. Anver,
D. C. Haines,
J. M. Melhorn,
P. Gorelick,
L. Yan, and J. G. Fox.
1996.
Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus.
Lab. Anim. Sci.
46:15-20[Medline].
|
| 40.
|
Ward, J. M.,
R. E. Benveniste,
C. H. Fox,
J. K. Battles,
M. A. Gonda, and J. G. Tully.
1996.
Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver.
Am. J. Pathol.
148:509-517[Abstract].
|
| 41.
|
Ward, J. M.,
J. G. Fox,
M. R. Anver,
D. C. Haines,
C. V. George,
M. J. Collins, Jr.,
P. L. Gorelick,
K. Nagashima,
M. A. Gonda, and R. V. Gilden.
1994.
Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.
J. Natl. Cancer Inst.
86:1222-1227[Abstract/Free Full Text].
|
| 42.
|
Whary, M. T., and J. G. Fox.
1998.
Mouse strains resistant and susceptible to Helicobacter hepaticus-related hepatitis differ in systemic immune response to experimental infection.
Gastroenterology
114:A1113.
|
| 43.
|
Whary, M. T.,
T. J. Morgan,
C. A. Dangler,
K. J. Gaudes,
N. S. Taylor, and J. G. Fox.
1998.
Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with Th1 cell-mediated immune response.
Infect. Immun.
66:3142-3148[Abstract/Free Full Text].
|
| 44.
|
Whary, M. T.,
L. S. Palley,
M. Batchelder,
J. C. Murphy,
L. Yan,
N. S. Taylor, and J. G. Fox.
1997.
Promotion of ulcerative duodenitis in young ferrets by oral immunization with Helicobacter mustelae and muramyl dipeptide.
Helicobacter
2:65-77[Medline].
|
Infection and Immunity, November 1998, p. 5477-5484, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Krishnan, N., Doster, A. R., Duhamel, G. E., Becker, D. F.
(2008). Characterization of a Helicobacter hepaticus putA Mutant Strain in Host Colonization and Oxidative Stress. Infect. Immun.
76: 3037-3044
[Abstract]
[Full Text]
-
Jergens, A. E, Wilson-Welder, J. H, Dorn, A., Henderson, A., Liu, Z., Evans, R. B, Hostetter, J., Wannemuehler, M. J
(2007). Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut
56: 934-940
[Abstract]
[Full Text]
-
Schmitz, J. M., McCracken, V. J., Dimmitt, R. A., Lorenz, R. G.
(2007). Expression of CXCL15 (Lungkine) in Murine Gastrointestinal, Urogenital, and Endocrine Organs. J. Histochem. Cytochem.
55: 515-524
[Abstract]
[Full Text]
-
Tomczak, M. F., Erdman, S. E., Davidson, A., Wang, Y. Y., Nambiar, P. R., Rogers, A. B., Rickman, B., Luchetti, D., Fox, J. G., Horwitz, B. H.
(2006). Inhibition of Helicobacter hepaticus-Induced Colitis by IL-10 Requires the p50/p105 Subunit of NF-{kappa}B. J. Immunol.
177: 7332-7339
[Abstract]
[Full Text]
-
Bohr, U. R. M., Selgrad, M., Ochmann, C., Backert, S., Konig, W., Fenske, A., Wex, T., Malfertheiner, P.
(2006). Prevalence and spread of enterohepatic helicobacter species in mice reared in a specific-pathogen-free animal facility.. J. Clin. Microbiol.
44: 738-742
[Abstract]
[Full Text]
-
Nambiar, P. R., Kirchain, S. M., Courmier, K., Xu, S., Taylor, N. S., Theve, E. J., Patterson, M. M., Fox, J. G.
(2006). Progressive Proliferative and Dysplastic Typhlocolitis in Aging Syrian Hamsters Naturally Infected with Helicobacter spp.: A Spontaneous Model of Inflammatory Bowel Disease. Vet Pathol
43: 2-14
[Abstract]
[Full Text]
-
Maggio-Price, L., Bielefeldt-Ohmann, H., Treuting, P., Iritani, B. M., Zeng, W., Nicks, A., Tsang, M., Shows, D., Morrissey, P., Viney, J. L.
(2005). Dual Infection with Helicobacter bilis and Helicobacter hepaticus in P-Glycoprotein-Deficient mdr1a-/- Mice Results in Colitis that Progresses to Dysplasia. Am. J. Pathol.
166: 1793-1806
[Abstract]
[Full Text]
-
Gebuhr, T. C., Kovalev, G. I., Bultman, S., Godfrey, V., Su, L., Magnuson, T.
(2003). The Role of Brg1, a Catalytic Subunit of Mammalian Chromatin-remodeling Complexes, in T Cell Development. JEM
198: 1937-1949
[Abstract]
[Full Text]
-
Asseman, C., Read, S., Powrie, F.
(2003). Colitogenic Th1 Cells Are Present in the Antigen-Experienced T Cell Pool in Normal Mice: Control by CD4+ Regulatory T Cells and IL-10. J. Immunol.
171: 971-978
[Abstract]
[Full Text]
-
Maloy, K. J., Salaun, L., Cahill, R., Dougan, G., Saunders, N. J., Powrie, F.
(2003). CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms. JEM
197: 111-119
[Abstract]
[Full Text]
-
Grehan, M., Tamotia, G., Robertson, B., Mitchell, H.
(2002). Detection of Helicobacter Colonization of the Murine Lower Bowel by Genus-Specific PCR-Denaturing Gradient Gel Electrophoresis. Appl. Environ. Microbiol.
68: 5164-5166
[Abstract]
[Full Text]
-
Garcia, A., Erdman, S. E., Xu, S., Feng, Y., Rogers, A. B., Schrenzel, M. D., Murphy, J. C., Fox, J. G.
(2002). Hepatobiliary Inflammation, Neoplasia, and Argyrophilic Bacteria in a Ferret Colony. Vet Pathol
39: 173-179
[Abstract]
[Full Text]
-
Maggio-Price, L., Shows, D., Waggie, K., Burich, A., Zeng, W., Escobar, S., Morrissey, P., Viney, J. L.
(2002). Helicobacter bilis Infection Accelerates and H. hepaticus Infection Delays the Development of Colitis in Multiple Drug Resistance-Deficient (mdr1a-/-) Mice. Am. J. Pathol.
160: 739-751
[Abstract]
[Full Text]
-
Burich, A., Hershberg, R., Waggie, K., Zeng, W., Brabb, T., Westrich, G., Viney, J. L., Maggio-Price, L.
(2001). Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol.
281: G764-G778
[Abstract]
[Full Text]
-
Esworthy, R. S., Aranda, R., Martin, M. G., Doroshow, J. H., Binder, S. W., Chu, F.-F.
(2001). Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am. J. Physiol. Gastrointest. Liver Physiol.
281: G848-G855
[Abstract]
[Full Text]
-
Solnick, J. V., Schauer, D. B.
(2001). Emergence of Diverse Helicobacter Species in the Pathogenesis of Gastric and Enterohepatic Diseases. Clin. Microbiol. Rev.
14: 59-97
[Abstract]
[Full Text]
-
Dieleman, L. A., Arends, A., Tonkonogy, S. L., Goerres, M. S., Craft, D. W., Grenther, W., Sellon, R. K., Balish, E., Sartor, R. B.
(2000). Helicobacter hepaticus Does Not Induce or Potentiate Colitis in Interleukin-10-Deficient Mice. Infect. Immun.
68: 5107-5113
[Abstract]
[Full Text]
-
Caradonna, L., Amati, L., Magrone, T., Pellegrino, N.M., Jirillo, E., Caccavo, D.
(2000). Invited review: Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. Innate Immunity
6: 205-214
[Abstract]
-
Livingston, R. S., Riley, L. K., Hook, R. R. Jr., Besch-Williford, C. L., Franklin, C. L.
(1999). Cloning and Expression of an Immunogenic Membrane-Associated Protein of Helicobacter hepaticus for Use in an Enzyme-Linked Immunosorbent Assay. CVI
6: 745-750
[Abstract]
[Full Text]
-
Ihrig, M., Schrenzel, M. D., Fox, J. G.
(1999). Differential Susceptibility to Hepatic Inflammation and Proliferation in AXB Recombinant Inbred Mice Chronically Infected with Helicobacter hepaticus. Am. J. Pathol.
155: 571-582
[Abstract]
[Full Text]
-
Fox, J. G., Gorelick, P. L., Kullberg, M. C., Ge, Z., Dewhirst, F. E., Ward, J. M.
(1999). A Novel Urease-Negative Helicobacter Species Associated with Colitis and Typhlitis in IL-10-Deficient Mice. Infect. Immun.
67: 1757-1762
[Abstract]
[Full Text]